Exploring testosterone therapy
Testosterone replacement therapy (TRT) is a crucial treatment for men with testosterone deficiency (TD) or hypogonadism, yet misconceptions persist. One common myth is that TRT increases the risk of cardiovascular disease (CVD).
To address these uncertainties, the American Food and Drug Administration commissioned the largest testosterone trial ever: A Study to Evaluate the Effect of Testosterone Replacement Therapy on the Incidence of Major Adverse Cardiovascular Events and Efficacy Measures in Hypogonadal Men (TRAVERSE).
Several sub-analyses have shown that TRT significantly improves sexual activity and function, hypogonadal symptoms, corrects anaemia in hypogonadal men with the condition, provides robust evidence on prostate safety, and demonstrates promise in alleviating depressive symptoms, particularly mood and energy levels. To learn more about the findings of the TRAVERSE study, click here.
In our second article, we investigate the long-term effects of opioid use for chronic non-cancer pain on androgen deficiency. Studies show that addressing androgen deficiency can significantly enhance affected individuals' quality of life. To read the article, click here.
Our third article looks at why some researchers refer to testosterone as the 'most misunderstood molecule in medicine’. To find out why, click here.
In our final article we investigate the link between loss of early morning erections and CV risk. To read the article, click here.
We also included several recent educational videos and webinars on TRT, which provide valuable insights into the latest recommendations and answer common questions. To access the links, please click here.
Photo credit: Shutterstock.com
Photo credit: Shutterstock.com
EDITORIAL
EDITOR: René Bosman
René.Bosman@newmedia.co.za
SUB EDITOR: Gill Abrahams
LAYOUT & DESIGN: Allison McCallum
ADVERTISING
ADVERTISING EXECUTIVE
Charissa Piek | 063 281 1205
Charissa.Piek@newmedia.co.za
DISTRIBUTION & SUBSCRIPTIONS
Felicity Garbers
Felicity.Garbers@newmedia.co.za
PUBLISHING TEAM
GENERAL MANAGER: Dev Naidoo
Head of Commercial - B2B: Johann Gerber
Johann.Gerber@newmedia.co.za
Production Manager: Angela Silver
ART DIRECTOR: David Kyslinger
CONTACT
Johannesburg Office: Ground Floor, 272 Pretoria Avenue, Randburg 2194
Postal Address: PO Box 784698, Sandton, Johannesburg, 2146
T +27(0)11 877 6111 F +27(0)11 713 9024
www.medicalacademic.co.za
PRINTING
Printed by CTP Printers
COVER PRICE
Specialist Forum per issue R80,00 VAT Incl.
ISSN: 2218-8282
Published by New Media, a division of Media24 (Pty) Ltd
MANAGEMENT TEAM
CEO: NEW MEDIA: Aileen Lamb
COMMERCIAL DIRECTOR: Maria Tiganis
STRATEGY DIRECTOR: Andrew Nunneley
CHIEF FINANCIAL OFFICER: Venette Malone
CEO: MEDIA24: Ishmet Davidson
HEAD OFFICE
8th floor, Media24 Centre, 40 Heerengracht, Cape Town 8001
PO Box 440, Green Point, Cape Town 8051
Tel: +27 (0)21 406 2002
www.newmedia.co.za
Unless previously agreed in writing, Specialist Forum owns all rights to all contributions, whether image or text.
SOURCES: Shutterstock, supplied images, editorial staff.
While precautions have been taken to ensure the accuracy of its contents and information given to readers, neither the editor, publisher, or its agents can accept responsibility for damages or injury which may arise therefrom. All rights reserved.
© Specialist Forum. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, photocopying, electronic, mechanical or otherwise without the prior written permission of the copyright owners.
Built with Shorthand